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Abstract: Positive psychology interventions (PPIs) have been shown to promote wellbeing in 
individuals with medical illness, although it is still unknown whether certain patient characteristics 
make participants more likely to benefit from such interventions. The present study tested whether, 
using individual patient data across five published PPI studies (three single-arm proof-of-concept 
trials, one non-randomized controlled trial, and one randomized controlled trial) in medically-ill 
persons, sociodemographic or psychological factors predicted subsequent change in wellbeing. In 208 
participants, lower baseline psychological wellbeing and optimism, and higher symptoms of 
depression and anxiety were associated with greater improvement in psychological symptoms during 
the PPI. Other factors were unrelated to symptom changes. In a sub-analysis of controlled studies, 
there were no group differences in the relationship between baseline factors and changes in wellbeing 
from pre- to post-intervention. Findings suggest that patients with more severe psychiatric and/or 
medical comorbidity are no less likely to benefit from a PPI compared to those with higher levels of 
health, even though these programs do not directly target psychological distress. PPIs may be widely 
applicable to medical patients, with lower psychological wellbeing a potential predictor of increased 
benefit.  
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1. Introduction 
 
Positive psychology interventions (PPIs) are treatment methods aiming to promote positive feelings, 
behaviors, and thoughts via structured activities such as expressing gratitude, performing acts of 
kindness, and using personal strengths (Sin & Lyubomirsky, 2009). In healthy individuals, these 
interventions have consistently improved psychological wellbeing and reduced symptoms of 
depression (Bolier et al., 2013). They differ from traditional psychological treatments that were 
developed to address a specific emotional or behavioral problem in that PPIs can benefit individuals 
with and without mental disorders. The two continua model of mental illness and mental health has 
demonstrated that mental illness and positive mental health are related, but operate on separate 
continua; thus the absence of mental illness does not by definition mean one has strong positive 
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psychological wellbeing (Keyes, 2005). PPIs operate from this conceptualization; wellbeing is not 
just the absence of mental disorders, but also the presence of positive psychological resources (Sin 
& Lyubomirsky, 2009).  
A growing body of literature suggests that PPIs may also improve psychological wellbeing in 
those with medical conditions, although findings have been inconsistent, with significant variability 
in the type of intervention delivered and in the patient population. A meta-analysis of PPIs on 
psychiatric and medical disorders found significant, small effect sizes of the interventions on 
depression and wellbeing, with no differences in effect size between medical and psychiatric 
populations (Chakhssi, Kraiss, Sommers-Spijkerman, & Bohlmeijer, 2018). In addition to the studies 
reviewed in the meta-analysis, a positive affect intervention was effective in improving medication 
adherence in a study of 256 African American participants with hypertension, compared to an 
education only control (Ogedegbe et al., 2012). Further, a positive affect skills intervention for 159 
individuals newly diagnosed with HIV led to higher levels of positive affect and less intrusive and 
avoidant thoughts compared to an attention-matched control up to 15 months after the intervention, 
but did not lead to significant differences in positive affect immediately after the intervention 
(Moskowitz et al., 2017). On the other hand, a six-week phone PPI for non-Hispanic white and non-
Hispanic African American veteran patients with osteoarthritis was not effective, compared to an 
attention-matched control on improving self-reported pain and functional difficulty (Hausmann et 
al., 2018). Psychological wellbeing in medical groups is particularly important, as it has been 
prospectively and independently associated with reduced mortality in those with physical illness 
(Lamers, Bolier, Westerhof, Smit, & Bohlmeijer, 2012), a link that is potentially mediated by 
participation in beneficial health behaviors such as physical activity (Steptoe, Wright, Kunz-Ebrecht, 
& Iliffe, 2006), healthy diet (Giltay, Geleijnse, Zitman, Buijsse, & Kromhout, 2007; Kelloniemi, Ek, & 
Laitinen, 2005), smoking abstinence (Giltay et al., 2007), and medication use (Leedham, Meyerowitz, 
Muirhead, & Frist, 1995), and that is independent of depression.  
Though it appears that PPIs may enhance wellbeing in populations with medical illness 
(Chakhssi et al., 2018; Huffman et al., 2016; Moskowitz et al., 2017; Ogedegbe et al., 2012), it is 
unknown whether factors such as gender, age, race/ethnicity, or psychological distress moderate the 
effect of PPIs. In a meta-analysis of 51 PPIs in healthy individuals (Sin & Lyubomirsky, 2009), older 
participants and those with higher levels of depression showed more benefit. The samples in this 
meta-analysis were primarily younger individuals; only three of the 51 studies tested PPIs in older 
adults. Further, the interventions were delivered with the primary aim of improving psychological 
wellbeing. Medical populations are typically older, and the goals of PPIs in this group tend to focus 
not only on psychological wellbeing but also on health-related quality of life and health behaviors. 
It has yet to be tested whether these same patterns of response to PPIs would emerge in a medical 
population, given the differences in age and life situation. Understanding whether participants in 
the medical setting with certain characteristics respond better to PP programs would be helpful for 
understanding the variability in results of PP randomized controlled trials thus far, and for 
maximizing intervention efficacy, allowing providers to offer them to those most likely to benefit. 
Such an approach is consistent with the increasing focus on personalized approaches to medicine. 
Accordingly, across five PPI studies performed and published by our research team in varied 
medical conditions and settings, we examined, using individual patient data, whether any 
demographic, medical, and psychological factors predicted subsequent change in psychological 
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outcomes, independent of the study population. We chose to include only this set of studies, due to 
the relative consistency in intervention content (weekly PPI delivered in person or by phone and 
with accompanying treatment manual) and outcome measures, and so that we could use individual 
patient level data to improve power of analyses. Based on prior research in healthy samples (Sin & 
Lyubomirsky, 2009), we hypothesized that older individuals, and those with higher levels of 
psychological distress pre-intervention, would show more improvement during the intervention. 
 
2. Method 
 
2.1 Study selection 
 
In total, our group has conducted six studies of PPIs in medical populations. One of these studies 
was excluded from this analysis (Nikrahan et al., 2016) because it did not use psychological outcome 
measures consistent with the other studies; thus we were unable to combine it with the other studies 
in the analysis. The remaining five studies are detailed below. 
 
2.2 Description of studies 
 
All studies involved instruction to complete weekly PP activities, explained by a study trainer, either 
in person or via phone, and written materials. Participants completed the activities on their own 
over the week and wrote about them, with review of what they did at the next session. They did not 
receive reminders between sessions. While intervention content did vary in some ways between 
studies, they all included a core focus on teaching skills to boost positive thoughts and feelings. At 
the beginning, each intervention provided education on the rationale for targeting psychological 
wellbeing to improve health, customized for the target population of that study. All studies also 
included content on how to develop new skills into habits that could be sustained beyond the study 
end. Each study was approved by the appropriate institutional review board, and all participants 
provided written informed consent.  
• Positive Emotions After a Coronary Event (PEACE) II (Huffman et al., 2016): This was a non-
randomized proof-of concept trial comparing an eight-week PP phone-based intervention to a 
treatment-as-usual control for patients after an acute coronary syndrome. The intervention 
included eight weekly 30-minute individual phone calls plus completion of PP activities between 
sessions. PP activities were based in gratitude (e.g., identifying positive events in the past week, 
expressing gratitude via a gratitude letter), strengths (e.g., remembering a past success, 
identifying and using a personal strength), and meaning (e.g., planning and engaging in acts of 
kindness, enjoyable and meaningful activities). Participants were recruited from the inpatient 
cardiac floors at a U.S. academic medical center and enrolled to participate in the study after 
discharge. Twenty-three participants received the PPI and completed follow-up data; 25 were 
later recruited and included in the control cohort.  
• PEACE III (Celano, Albanese, et al., 2018): This was a randomized factorial trial comparing eight 
variations of a phone-based PPI in 128 participants after an acute coronary syndrome. 
Participants were recruited from the inpatient cardiac floors at a U.S. academic medical center 
and enrolled to participate in the study after hospital discharge. The intervention included eight 
weekly 30-minute individual phone calls plus completion of PP activities between sessions. 
Activities were largely the same as those in PEACE II, with the addition of two more: capitalizing 
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on positive events and identifying humor in everyday life. Half received booster sessions over 
the subsequent eight weeks after completing the eight-week intervention; half received an 
intervention combining PP with motivational interviewing to increase physical activity; and half 
were instructed to engage in PP activities daily, while the other half were instructed to do so 
weekly (although all only spoke with their interventionist once per week). There was no control 
condition.  
• Optimism training intervention (Mohammadi et al., 2018): This study, conducted in Iran, was a 
randomized controlled trial of 61 participants with chronic coronary heart disease who had 
completed a cardiac rehabilitation program at an academic medical center. Participants were 
randomly assigned either to an eight-week in-person group optimism training intervention (n = 
31) or an attention-matched educational control condition (n = 30). Each group session was two 
hours long; 17 positive psychological exercises were taught across the eight sessions. The 
intervention content had some overlap with other studies (e.g., identifying positive events in the 
past week), but was overall focused on optimism and used different exercises to elicit this (e.g., 
positive interpretations of life events, optimism in social relationships, detailing one’s best 
possible self and how to take steps to reach it, and using optimism at different times of day). The 
control condition provided extended education about cardiovascular illness and modifying risk 
factors.  
• Researching Emotions and Cardiac Health (REACH; Celano, Freedman, Beale, Gomez-Bernal, 
& Huffman, 2018): This one-armed pilot trial examined a ten-week phone-based PPI in 11 
outpatients with heart failure. The intervention included ten weekly 30-minute individual phone 
calls plus completion of PP activities between sessions. The PP activities were identical to those 
in PEACE II, with several additional weeks devoted to integrating skills into daily life. 
Participants were patients at a U.S. academic medical center and were recruited through primary 
care providers. The intervention also included a motivational interviewing component targeting 
health behavior engagement. There was no control condition. 
• Positive Psychology for Type 2 Diabetes (PP for T2D; DuBois, Millstein, Celano, Wexler, & 
Huffman, 2016): This was a one-armed proof-of-concept trial examining an eight-week phone-
based PPI in 15 participants with type 2 diabetes. The intervention included eight weekly 30-
minute individual phone calls plus completion of PP activities between sessions. The PP 
activities were identical to those in PEACE II. Participants were inpatients or outpatients at a 
U.S. academic medical center. There was no control condition. 
 
2.3 Measures 
 
Questionnaires were completed at the start and end of each intervention. Therefore, the length of 
time between baseline and follow-up measures was ten weeks for REACH and eight weeks for the 
other studies.  
Depression and anxiety were measured in all five studies, using the Hospital Anxiety and 
Depression Scale (HADS; Bjelland, Dahl, Haug, & Neckelmann, 2002), which was developed to 
measure anxiety and depression in patients with medical illness by excluding physical/somatic 
symptom assessment. It includes seven items for depression (HADS-D) and seven for anxiety 
(HADS-A), with a range of scores from 0-21 for each subscale. Both subscales have shown good 
internal consistency (M α = 0.82 for HADS-D and 0.83 for HADS-A; Bjelland et al., 2002).  
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Dispositional optimism was measured in all five studies using the Life Orientation Test – Revised 
(LOT-R; range 6-24; Scheier, Carver, & Bridges, 1994), a ten-item scale including six active and four 
filler items. This scale has shown good test-retest reliability and internal consistency (Glaesmer et 
al., 2012; Scheier et al., 1994). 
Positive affect was measured in four studies (Celano, Albanese, et al., 2018; Celano, Freedman, et 
al., 2018; Huffman et al., 2016; Mohammadi et al., 2018) with the positive affect subscale of the 
Positive and Negative Affect Schedule (PANAS; range 10-50; Watson, Clark, & Tellegen, 1988), 
which asks participants to rate their experience of ten types of positive affect over the past week. 
This measure has shown good internal consistency (α = 0.86). 
Health-related quality of life was measured in three studies (Celano, Albanese, et al., 2018; Celano, 
Freedman, et al., 2018; Huffman et al., 2016) with the Medical Outcomes Study Short Form-12 (SF-
12; Ware, Kosinski, Turner-Bowker, & Gandek, 2005), a 12-item questionnaire that includes both 
mental and physical health components (MCS and PCS) with demonstrated internal consistency (α 
> 0.70; Luo et al., 2003). 
Demographic and health information, including age, gender, marital status, and medical 
comorbidity, was collected through chart review at time of study enrollment. Age and gender data 
were available for all five studies, marital status for 4/5 studies (n = 248; Celano, Albanese, et al., 
2018; Celano, Freedman, et al., 2018; Huffman et al., 2016; Mohammadi et al., 2018), and medical 
comorbidity for 3/5 studies (n = 187; Celano, Albanese, et al., 2018; Celano, Freedman, et al., 2018; 
Huffman et al., 2016). 
 
2.4 Data analysis 
 
The association of predictors with the change in each outcome measure was estimated in two ways. 
Combining data from all five studies into one dataset, we estimated the difference in the change of 
each outcome with time based on each baseline predictor in all participants who received the PP 
intervention, using a random intercept linear mixed effects model with main effects for time, the 
predictor, the predictor-by-time interaction, and a categorical effect of study. The regression 
coefficient for the interaction term from this model was the focus of the analysis. In a second analysis 
including only the two studies that included both PPI and control arms (Huffman et al., 2016; 
Mohammadi et al., 2018), we estimated the difference in the effect of each predictor on the change 
in each outcome with time, comparing the PPI participants to the control group participants. In this 
analysis, we fit a random intercept linear mixed effect model with effects for time, PPI, the predictor, 
and all two-way and three-way interactions. The three-way interaction from this model estimated 
whether the predictor was associated with a different impact on the change with time, comparing 
the PPI and control arm. A study effect was also included in the analysis to account for differences 
between the two studies.  
For all analyses, continuous outcome and predictor variables were standardized by dividing by 
the standard deviation of the variable. This approach allows the mixed model coefficients to estimate 
the mean change with time in the standardized outcome for a one standard deviation increase in the 
predictor, which provides a measure of the effect size that can be compared across analyses. All 
analyses were completed in the statistical package R (www.r-project.org) with the nlme library. A 
p-value below 0.05 was considered significant, and all tests were two-tailed.  
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3. Results 
 
3.1 Participants 
 
Across studies, 208 participants received a PPI, and 55 were in a control cohort. Mean age was 60.7 
years (SD = 11.4), 46% of participants were women, and 68% of those with information provided (n 
= 169/248) were married. Of participants in the United States (four studies; Celano, Albanese, et al., 
2018; Celano, Freedman, et al., 2018; DuBois et al., 2016; Huffman et al., 2016), 78% were white. 
Participants had a body mass index in the overweight range on average (M = 29.4, SD = 5.8); 40% 
had diabetes, 67% had hyperlipidemia, and 77% had hypertension. Summary statistics for each 
outcome measure at baseline and follow-up are provided for each study in Table 1. A recruitment 
flowchart for all studies combined can be found in Figure 1 (below). 
 
Table 1. Descriptive information about each measure for each study at the start and end of the 
intervention 
 
  N, M (SD) 
Study Timepoint LOT-Ra PANASb HADS-Ac HADS-Dc SF12 PCSd SF12 MCSd 
PEACE II 
Baseline 
48, 23.69 
(4.62) 
48, 35.15 
(7.87) 
47, 7.19 
(5.39) 
47, 4.94 
(4.05) 
47, 41.29 
(11.73) 
47, 47.49 
(11.97) 
8 Weeks 
42, 24.57 
(5.01) 
42, 37.21 
(7.92) 
41, 5.00 
(4.09) 
41, 3.80 
(3.60) 
44, 41.08 
(11.61) 
44, 49.89 
(10.45) 
PEACE III 
Baseline 
126, 22.94 
(5.82) 
128, 36.38 
(7.54) 
126, 7.02 
(4.60) 
126, 4.84 
(3.78) 
126, 36.81 
(11.43) 
126, 47.33 
(12.69) 
8 Weeks 
89, 24.25 
(6.02) 
85, 38.29 
(7.62) 
87, 5.22 
(4.29) 
87, 3.57 
(3.57) 
89, 40.97 
(11.46) 
89, 52.05 
(9.64) 
Optimism 
Training 
Baseline 
61, 19.00 
(2.85) 
61, 27.75 
(8.00) 
61, 7.02 
(4.18) 
61, 7.34 
(4.26) 
- - 
8 Weeks 
58, 21.00 
(3.41) 
58, 27.81 
(7.58) 
58, 5.31 
(3.60) 
58, 5.71 
(3.72) 
- - 
REACH 
Baseline 
11, 27.18 
(2.48) 
11, 38.73 
(3.35) 
11, 4.00 
(2.19) 
11, 1.64 
(1.43) 
11, 46.03 
(12.86) 
11, 54.21 
(6.30) 
10 Weeks 
8, 28.75 
(1.39) 
9, 41.56 
(4.77) 
9, 2.22 
(1.64) 
9, 1.44 
(1.42) 
9, 48.43 
(8.68) 
9, 57.70 
(3.89) 
PP for T2D 
Baseline 
15, 19.00 
(6.83) 
- 
15, 7.87 
(4.19) 
15, 7.00 
(3.66) 
- - 
8 Weeks 
8, 24.38 
(3.34) 
- 
8, 6.63 
(3.25) 
8, 3.38 
(1.06) 
- - 
aLife Orientation Test – Revised; bPositive and Negative Affect Scale – positive subscale; cHospital 
Anxiety and Depression Scale; dShort Form 12 physical and mental health components 
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Figure 1. Recruitment flowchart combined across the five studies 
 
 
3.2 Predictors of change during the PPI  
 
Baseline clinical and demographic variables predicted few differences in the change in psychological 
symptoms with time (Table 2 below). Of all relationships tested, only age was statistically 
significantly associated with change over time in the depression score, such that younger 
participants showed a larger pre- to post-intervention decrease in depressive symptoms. 
Psychosocial baseline variables predicted changes in outcome over time, such that those with 
worse baseline functioning had a greater improvement in wellbeing. Specifically, lower baseline 
mental health-related quality of life was associated with a larger improvement in positive affect, 
anxiety, and depression (see Table 2 below). Further, lower baseline optimism was associated with 
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a larger improvement in depression and anxiety pre- to post-intervention, higher baseline anxiety 
predicted a larger decrease in depression, and higher baseline depression predicted a larger 
improvement in anxiety and optimism. 
 
Table 2. Associations between baseline characteristics and change in psychological constructs 
during the intervention 
 
 Estimate (95% Confidence Interval) 
Predictor LOT-Rb PANASc HADS-Ad HADS-Dd 
Age -0.08 (-0.22, 0.07) -0.07 (-0.24, 0.10) 0.05 (-0.08, 0.18) 0.16 (0.02, 0.30)* 
Gender 0.14 (-0.14, 0.43) -0.04 (-0.37, 0.30) 0.16 (-0.09, 0.41) 0.01 (-0.27, 0.29) 
White 0.01 (-0.41, 0.42) 0.22 (-0.25, 0.69) -0.16 (-0.53, 0.21) 0.01 (-0.42, 0.43) 
Marital 
Status 
0.23 (-0.08, 0.54) 0.00 (-0.35, 0.35) 0.08 (-0.20, 0.36) 0.13 (-0.18, 0.44) 
Medical 
Comorbidity 
0.05 (-0.12, 0.23) -0.18 (-0.38, 0.03)^ -0.01 (-0.17, 0.15) 0.11 (-0.06, 0.29) 
SF12-PCSa 0.05 (-0.12, 0.21) 0.16 (-0.03, 0.35)^ -0.01 (-0.16, 0.14) 0.02 (-0.14, 0.19) 
SF12-MCSa -0.07 (-0.23, 0.09) -0.26 (-0.43, -0.08)** 0.25 (0.11, 0.39)** 0.38 (0.23, 0.53)*** 
LOT-Rb -- -0.07 (-0.24, 0.10) 0.26 (0.13, 0.39)*** 0.31 (0.17, 0.45)*** 
PANASc -0.08 (-0.22, 0.07) -- 0.16 (0.03, 0.29)* 0.23 (0.09, 0.37)** 
HADS-Ad 0.12 (-0.02, 0.26)^ 0.05 (-0.11, 0.21) -- -0.32 (-0.45, -0.19)*** 
HADS-Dd 0.19 (0.05, 0.33)** 0.11 (-0.05, 0.27) -0.22 (-0.34, -0.10)*** -- 
Note: Estimate is the estimated regression coefficient for the interaction term from the linear mixed model, 
which corresponds to the difference in change with time in standardized outcome for a one standard deviation 
change in each continuous predictor variable. For dichotomous predictors, the difference in the change with 
time in standardized outcome between the groups is presented. Analyses included a categorical effect of study. 
aShort-Form 12 Physical and Mental Health Components. bLife Orientation Test – Revised. cPositive and 
Negative Affect Schedule – positive affect subscale. dHospital Anxiety and Depression Scale. ^p < 0.10; *p < 
0.05; **p < 0.01; ***p < 0.001 
 
When studies with both a PPI and a control were used to assess for a differential impact of the 
predictor on the change over time comparing the two arms, there was no significant effect for any 
of the predictors (Table 3 below). 
There were trends that approached significance for a difference between conditions in the 
relationship between baseline anxiety and change in positive affect, and between baseline 
depression and change in optimism; those with higher anxiety showed more of an increase in 
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positive affect in the PP, compared to the control condition, and those with higher depression 
showed more of an increase in optimism in the PP, compared to the control condition. 
 
Table 3. Difference in effect of each predictor variable on change in psychological constructs 
during the intervention in the PPI compared to control condition, for studies that included a 
control 
 
 Estimate (95% Confidence Interval) 
 LOT-Rb PANASc HADS-Ad HADS-Dd 
Age -0.21 (-0.68, 0.25) -0.08 (-0.50, 0.35) 0.18 (-0.26, 0.62) 0.1 (-0.32, 0.51) 
Gender 0.44 (-0.55, 1.43) -0.66 (-1.56, 0.23) -0.15 (-1.08, 0.79) -0.11 (-0.97, 0.75) 
White -0.79 (-3.08, 1.49) 0.5 (-1.40, 2.39) 1.18 (-1.48, 3.84) 1.31 (-1.07, 3.69) 
Marital Status 0.99 (-0.23, 2.21) -0.49 (-1.59, 0.61) 0.32 (-0.82, 1.47) 0.78 (-0.27, 1.84) 
Medical 
Comorbidity 
0.27 (-0.50, 1.03) 0.00 (-0.71, 0.70) 0.19 (-0.57, 0.96) 0.2 (-0.56, 0.96) 
SF12-PCSa 0.47 (-0.37, 1.30) 0.12 (-0.57, 0.81) 0.09 (-0.72, 0.90) 0.15 (-0.53, 0.83) 
SF12-MCSa 0.18 (-0.66, 1.02) -0.35 (-0.98, 0.28) -0.37 (-1.05, 0.31) -0.04 (-0.72, 0.63) 
LOT-Rb -- 0.07 (-0.35, 0.49) 0.18 (-0.23, 0.59) 0.11 (-0.31, 0.54) 
PANASc -0.22 (-0.66, 0.22) -- 0.25 (-0.14, 0.64) 0.12 (-0.24, 0.48) 
HADS-Ad 0.05 (-0.40, 0.49) 0.38 (-0.01, 0.77)^ -- -0.04 (-0.40, 0.32) 
HADS-Dd 0.39 (-0.07, 0.86)^ 0.32 (-0.06, 0.70) 0.06 (-0.31, 0.42) -- 
Note: Estimate is the estimated regression coefficient for the three-way interaction term from the linear mixed 
model, which corresponds to the difference in impact of standardized predictor for continuous predictors or 
group for dichotomous predictors on change with time in standardized outcome, comparing participants in 
PP arm to participants in control arm. Results from the two studies with control groups (Huffman et al., 2016; 
Mohammadi et al., 2018). Analyses included a categorical effect of study. aShort-Form 12 Physical and Mental 
Health Components. bLife Orientation Test – Revised. cPositive and Negative Affect Schedule – positive affect 
subscale. dHospital Anxiety and Depression Scale. ^p < 0.10 
 
4. Discussion 
 
In summary, across five PPI studies in several medical populations, baseline clinical and 
demographic factors were minimally associated with change in psychological wellbeing during the 
intervention. However, lower baseline psychological wellbeing (measured via mental health-related 
quality of life, optimism, and positive affect) and higher baseline depression and anxiety were 
associated with larger improvements in depression and anxiety post-intervention. Additionally, 
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lower baseline mental health-related quality of life was associated with a greater increase in positive 
affect, and higher baseline depression predicted a larger increase in optimism. Of note, in the sub-
analysis of the two studies with a control condition (Huffman et al., 2016; Mohammadi et al., 2018), 
the relationship between baseline symptoms and change in depression and anxiety did not differ 
between groups, though a trend toward greater PP-associated improvements in positive affect and 
optimism existed among those with higher baseline anxiety and depression, respectively. 
The fact that higher baseline distress was associated with greater wellbeing improvement (in the 
overall analysis) or no less wellbeing improvement (in the sub-analysis) may signal that PPIs can be 
successfully applied to patients who are experiencing higher psychological distress. It is possible, 
however, that regression to the mean explains these results, as those with higher baseline symptoms 
are more likely to reduce symptoms over time, regardless of an intervention. The fact that baseline 
symptoms did not predict improvement with the PPI compared to the control in the sub-analysis is 
particularly concerning for this reason, although that sub-analysis is also limited by a smaller sample 
size. While the present study cannot prove that PPIs work better for those with higher baseline 
symptoms, it does at least suggest that PPIs are not less effective or harmful for those with 
depression or anxiety. As PPIs focus on promoting wellbeing rather than directly targeting 
depression or anxiety, some have wondered whether they could be useful in individuals with 
significant symptoms of depression or anxiety (Sin & Lyubomirsky, 2009). Such findings are 
consistent with prior works in healthy persons that found depression improvements with PPIs to be 
greatest in those with higher baseline levels of depression (Layous, Chancellor, Lyubomirsky, Wang, 
& Doraiswamy, 2011; Sin & Lyubomirsky, 2009), as well as those finding that high baseline positive 
affect can limit the effectiveness of PPIs (Froh, Kashdan, Ozimkowski, & Miller, 2009). On the other 
hand, Celano and colleagues (2017) found a PPI to be less effective in improving hopelessness than 
a control condition involving recall of daily events, in a sample of patients recently hospitalized for 
depression and suicidal ideation. Therefore, PPIs may be best suited for individuals with mild-to-
moderate depression. The present study extends these findings to patients experiencing substantial 
medical illnesses, for whom promotion of wellbeing may be important to recovery and prognosis 
(Chida & Steptoe, 2008).  
There were no consistent relationships between demographic characteristics and outcomes with 
these interventions. While younger participants showed a larger decrease in depressive symptoms 
over time, this is likely explained by their higher baseline depressive symptoms. In their meta-
analysis of non-medical populations, Sin and Lyubomirsky (2009) found that PPIs were more 
effective in older participants, and in their meta-analyses of PP randomized controlled trials, Bolier 
and colleagues (2013) did not identify any sociodemographic traits that predicted response to the 
intervention. The lack of a meaningful relationship between demographic variables and change in 
psychological symptoms in our study suggests that PPIs in persons with medical illness may be 
applicable to a wide range of individuals, across age, gender, race, and medical comorbidity.  
Given that the programs in this analysis all required a trained staff member to deliver the 
intervention, either in person or over the phone every week, the feasibility and cost of disseminating 
such a program in a healthcare setting is important to consider. Remote delivery via telephone does 
improve feasibility in that participants do not have to attend extra appointments, for which 
transportation can be difficult and costly. However, trained staff must spend significant time on 
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intervention delivery for this level of intervention intensity. Adaptation of PPIs to digital platforms 
(e.g., apps, text messages) may help to reduce cost and interventionist burden in the future.  
Strengths of this analysis include a sample of participants from several medical populations who 
received carefully developed PPIs, and our ability to use all study data to analyze individual 
participant-level data is a more powerful approach than standard meta-analyses (Panagioti et al., 
2016). This was also the first such analysis of predictors of PPI response in patients with medical 
illness. The analysis also had several limitations. The interventions were all conducted at academic 
medical centers, and only in patients with heart disease or diabetes, and therefore our findings may 
not generalize broadly. A lack of a control condition in three of the five studies examined limits our 
ability to attribute significant relationships to the PPI itself, and some variables (e.g., medical 
comorbidities) were not measured in all studies. Four studies were quite similar in terms of 
intervention content, while the fifth differed (Mohammadi et al., 2018), which could obscure trends 
that would have been seen with a more consistent intervention. On the other hand, PPIs are variable 
in the literature, and an understanding of predictors of response to different types of PPIs would be 
useful. Further, multiple analyses increased our risk of type I error. However, this was an 
exploratory study aimed to identify potential areas for future research, and a Bonferroni correction 
would cause our significance threshold to be p = 0.0125, which most of our significance values fell 
below, suggesting that the findings were largely not due to type I error. 
In sum, PPIs appear to be similarly applicable to medically ill patients with a wide range of 
baseline characteristics, and higher levels of distress do not appear to impede the effect of these 
programs in medical populations. Future research should examine predictors of response to PPIs in 
larger, randomized controlled trials to inform delivery of interventions to those most likely to 
benefit.  
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